Live from the NIH registry
Studies recruiting near Lorain right now
Top 25 of 1,303 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
University Hospital Rainbow Babies & Children's Hospital — Cleveland, Ohio (25.6 mi)
· Sponsor: University of Michigan
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
Cleveland Clinic — Cleveland, Ohio (25.6 mi)
· Sponsor: University of Pennsylvania
Proton Therapy Patient Registry
Treatment With Proton Beam Radiation Therapy
N/A
Observational 999 participants sought
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio (25.6 mi)
· Sponsor: Case Comprehensive Cancer Center
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Cleveland Clinic Foundation (Adults and Pediatrics) — Cleveland, Ohio (25.6 mi)
· Sponsor: Pierre Fabre Medicament
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
Carcinoma, Non-Small-Cell Lung
Phase 1, Phase 2
Interventional 450 participants sought
Cleveland Clinic Main ( Site 0006) — Cleveland, Ohio (25.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
University Hospitals Cleveland Medical Center — Cleveland, Ohio (25.6 mi)
· Sponsor: Syndax Pharmaceuticals
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma
Phase 2
Interventional 25 participants sought
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio (25.6 mi)
· Sponsor: Melissa Lumish
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Rainbow Babies and Childrens Hospital — Cleveland, Ohio (25.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
KRAS G12C Mutation, KRAS G12S Mutation
Phase 1
Interventional 140 participants sought
Cleveland Clinic, Taussig Cancer Institute — Cleveland, Ohio (25.6 mi)
· Sponsor: Kumquat Biosciences Inc.
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Neurology Institute Epilepsy Center of Cleveland Clinic — Cleveland, Ohio (25.6 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Cleveland, Ohio (25.6 mi)
· Sponsor: Sameek Roychowdhury
Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery
Type 1 Diabetes (T1D)
N/A
Interventional 16 participants sought
University Hospitals Cleveland Medical Center — Cleveland, Ohio (25.6 mi)
· Sponsor: University Hospitals Cleveland Medical Center
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
North Star Medical Research — Middleburg Heights, Ohio (20.0 mi)
· Sponsor: Eli Lilly and Company
Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Open Angle Glaucoma (OAG)
N/A
Interventional 165 participants sought
Cleveland Clinic- Cole Eye Institute — Cleveland, Ohio (25.6 mi)
· Sponsor: Avisi Technologies Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
University Hospitals Cleveland Medical Center — Cleveland, Ohio (25.6 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Cleveland Clinic — Cleveland, Ohio (25.6 mi)
· Sponsor: Boehringer Ingelheim
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Cleveland Clinic — Cleveland, Ohio (25.6 mi)
· Sponsor: Genentech, Inc.
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
The Cleveland Clinic Foundation — Cleveland, Ohio (25.6 mi)
· Sponsor: Abbott Medical Devices
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
University Hospitals Cleveland Medical Center — Cleveland, Ohio (25.6 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 83 participants sought
University Hospitals Cleveland Medical Center — Cleveland, Ohio (25.6 mi)
· Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Cleveland Clinic | Cole Eye Institute — Cleveland, Ohio (25.6 mi)
· Sponsor: VisionCare, Inc.
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Relapsing Multiple Sclerosis
Phase 4
Interventional 100 participants sought
Cleveland Clinic — Cleveland, Ohio (25.6 mi)
· Sponsor: University of Colorado, Denver
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Fairview Hospital — Cleveland, Ohio (25.6 mi)
· Sponsor: Hoffmann-La Roche
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
Atrial Fibrillation, Obesity
Phase 2
Interventional 100 participants sought
Cleveland Clinic — Cleveland, Ohio (25.6 mi)
· Sponsor: The Cleveland Clinic
Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy
Pregnancy Related, Prematurity
N/A
Interventional 360 participants sought
MetroHealth Medical Center — Cleveland, Ohio (25.6 mi)
· Sponsor: Case Western Reserve University